Published in PLoS One on February 24, 2011
Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis. Lancet Infect Dis (2015) 3.95
Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities. Lancet Infect Dis (2015) 2.42
Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg Infect Dis (2016) 1.70
What makes an academic paper useful for health policy? BMC Med (2015) 1.57
Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa. Am J Trop Med Hyg (2015) 1.18
Artemisinin resistance--modelling the potential human and economic costs. Malar J (2014) 1.01
An economic evaluation of home management of malaria in Uganda: an interactive Markov model. PLoS One (2010) 0.93
Cost effectiveness and resource allocation of Plasmodium falciparum malaria control in Myanmar: a modelling analysis of bed nets and community health workers. Malar J (2015) 0.93
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. Malar J (2014) 0.89
Inpatient child mortality by travel time to hospital in a rural area of Tanzania. Trop Med Int Health (2014) 0.82
Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings. PLoS One (2016) 0.80
[Frequency of severe anemia in children aged 2 months to 15 years at Mother and Child Centre of the Chantal Biya Foundation Yaounde, Cameroon]. Pan Afr Med J (2012) 0.79
Global priorities for research and the relative importance of different research outcomes: an international Delphi survey of malaria research experts. Malar J (2016) 0.79
Geographical concentration of falciparum malaria treated in the UK and delay to treatment with artesunate in severe cases: an observational study. BMJ Open (2012) 0.78
Defining technical errors in laparoscopic surgery: a systematic review. Surg Endosc (2013) 0.77
Performance Requirements to Achieve Cost-Effectiveness of Point-of-Care Tests for Sepsis Among Patients with Febrile Illness in Low-Resource Settings. Am J Trop Med Hyg (2015) 0.77
Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt. BMC Med Res Methodol (2014) 0.77
Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania. Pharmacoeconomics (2016) 0.75
Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia. Malar J (2016) 0.75
Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries. BMJ Open (2014) 0.75
Provider compliance to artemisinin-based combination therapy at primary health care facilities in the middle belt of Ghana. Malar J (2015) 0.75
Where and why are 10 million children dying every year? Lancet (2003) 28.59
Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med (2005) 13.27
Research guidelines for the Delphi survey technique. J Adv Nurs (2000) 12.05
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ (2004) 11.96
The Delphi technique: myths and realities. J Adv Nurs (2003) 7.07
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet (1999) 5.82
Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ (2008) 4.46
The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis. BMJ (2008) 4.02
Why do some African children develop severe malaria? Parasitol Today (1991) 3.88
Consulting the oracle: ten lessons from using the Delphi technique in nursing research. J Adv Nurs (2006) 3.63
Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ (2005) 3.05
Delayed care seeking for fatal pneumonia in children aged under five years in Uganda: a case-series study. Bull World Health Organ (2008) 2.88
Delphi as a method to establish consensus for diagnostic criteria. J Clin Epidemiol (2003) 2.74
Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions. J Clin Nurs (2003) 2.06
What kind of evidence is it that Evidence-Based Medicine advocates want health care providers and consumers to pay attention to? BMC Health Serv Res (2002) 2.05
A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa. Am J Trop Med Hyg (2004) 1.91
An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria. Malar J (2008) 1.90
Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health (2004) 1.89
Comparison of the cost and cost-effectiveness of insecticide-treated bednets and residual house-spraying in KwaZulu-Natal, South Africa. Trop Med Int Health (2001) 1.80
Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults. AIDS Care (2006) 1.43
Strategies for diagnosis and treatment of suspected leptospirosis: a cost-benefit analysis. PLoS Negl Trop Dis (2010) 1.16
The management of severe falciparum malaria. Am J Respir Crit Care Med (2003) 1.11
Problems of malaria control in tropical Africa. Br Med J (1954) 1.06
Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. Int J Epidemiol (1992) 1.03
Identifying the characteristics of optimum practice: findings from a survey of practice experts in nursing, midwifery and health visiting. J Adv Nurs (1995) 0.85
Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2009) 33.25
Overcoming health-systems constraints to achieve the Millennium Development Goals. Lancet (2004) 15.43
The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis (2004) 14.42
Evolution of MRSA during hospital transmission and intercontinental spread. Science (2010) 13.34
Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med (2005) 13.27
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet (2005) 12.98
Typhoid fever. N Engl J Med (2002) 12.96
A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med (2009) 12.82
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ (2004) 11.96
Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol (2005) 11.88
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet (2012) 11.82
Mortality after fluid bolus in African children with severe infection. N Engl J Med (2011) 10.99
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med (2004) 10.14
Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ (2007) 10.03
Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet (2008) 9.05
The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med (2008) 8.95
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet (2008) 8.50
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med (2005) 8.36
Shrinking the malaria map: progress and prospects. Lancet (2010) 8.21
Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg (2004) 8.13
Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet (2007) 7.98
Satellite imagery in the study and forecast of malaria. Nature (2002) 7.84
Climate change and the resurgence of malaria in the East African highlands. Nature (2002) 7.70
The decline in paediatric malaria admissions on the coast of Kenya. Malar J (2007) 7.45
Malaria. Lancet (2005) 7.37
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med (2008) 7.28
Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med (2010) 7.22
Improved diagnostic testing and malaria treatment practices in Zambia. JAMA (2007) 7.15
Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya. Lancet (2004) 7.13
Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis (2012) 6.94
Increasing coverage and decreasing inequity in insecticide-treated bed net use among rural Kenyan children. PLoS Med (2007) 6.92
Insecticide-treated net coverage in Africa: mapping progress in 2000-07. Lancet (2008) 6.91
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
The burden of malaria mortality among African children in the year 2000. Int J Epidemiol (2006) 6.64
Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis (2008) 6.53
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34
Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol (2010) 6.28
A major genome region underlying artemisinin resistance in malaria. Science (2012) 6.25
The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis (2010) 6.23
Delayed breastfeeding initiation increases risk of neonatal mortality. Pediatrics (2006) 6.05
Mixed-species malaria infections in humans. Trends Parasitol (2004) 6.01
The trypanosomiases. Lancet (2003) 5.96
Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg (2006) 5.91
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS One (2009) 5.81
Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay? Lancet Infect Dis (2003) 5.74
Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J (2011) 5.65
The malaria Atlas Project: developing global maps of malaria risk. PLoS Med (2006) 5.51
The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet (2011) 5.42
Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol (2007) 5.40
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Forecasting, warning, and detection of malaria epidemics: a case study. Lancet (2003) 5.27
Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22
Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med (2010) 4.89
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J (2007) 4.85
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis (2012) 4.84
Effect of the Newhints home-visits intervention on neonatal mortality rate and care practices in Ghana: a cluster randomised controlled trial. Lancet (2013) 4.80
Maternal health in poor countries: the broader context and a call for action. Lancet (2006) 4.72
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med (2005) 4.65
Rapid diagnostic tests for malaria at sites of varying transmission intensity in Uganda. J Infect Dis (2008) 4.60
Quantifying the impact of human mobility on malaria. Science (2012) 4.60
Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg (2007) 4.58
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA (2005) 4.57
Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med (2007) 4.56
Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved? Am J Trop Med Hyg (2007) 4.51
Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (2010) 4.50
Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med (2005) 4.47
Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ (2008) 4.46
Manslaughter by fake artesunate in Asia--will Africa be next? PLoS Med (2006) 4.46
Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis (2005) 4.44
Mapping the global extent of malaria in 2005. Trends Parasitol (2006) 4.43
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
How to achieve international action on falsified and substandard medicines. BMJ (2012) 4.36
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis (2007) 4.35
Population distribution, settlement patterns and accessibility across Africa in 2010. PLoS One (2012) 4.34
Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J (2008) 4.33
Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006. BMJ (2008) 4.32
Health financing to promote access in low income settings-how much do we know? Lancet (2004) 4.31